Is endoscopic third ventriculostomy an internal shunt alone?

Area of Science:

• Neurosurgery
• Neurology
• Pediatric Neurosurgery

Background:

• Hydrocephalus is a condition characterized by abnormal accumulation of cerebrospinal fluid (CSF) within the brain's ventricles.
• Endoscopic third ventriculostomy (ETV) is a neurosurgical procedure used to treat certain types of hydrocephalus.
• Understanding the precise mechanism of ETV is crucial for optimizing treatment outcomes.

Purpose of the Study:

• To elucidate the mechanism of endoscopic third ventriculostomy (ETV) across diverse hydrocephalus etiologies.
• To correlate intraoperative findings with ETV success rates in different hydrocephalus patient groups.

Main Methods:

• Retrospective review of 140 patients with hydrocephalus treated with ETV.
• Classification of patients into three groups: obstructive hydrocephalus, post-infection/hemorrhage hydrocephalus, and idiopathic normal pressure hydrocephalus.
• Analysis of hydrocephalus type, etiology, intraoperative third ventricular floor mobility, patient outcomes, and shunt-independence rates.

Main Results:

• Overall ETV success rate was 79.3% (111/140 shunt-free patients).
• Success rates varied by group: 88% for obstructive hydrocephalus, 60% for post-infection/hemorrhage, and 73.4% for idiopathic normal pressure hydrocephalus.
• Significant third ventricular floor mobility observed in 86.4% of cases post-ETV, particularly in obstructive hydrocephalus.

Conclusions:

• ETV success in various hydrocephalus forms, coupled with observed third ventricular floor mobility, suggests a primary mechanism of restoring ventricular wall pulsatility.
• This restoration facilitates CSF flow into subarachnoid spaces, normalizing CSF dynamics.
• ETV functions not merely as an internal shunt but fundamentally enhances the brain's intrinsic pulsatility for CSF circulation.